Completed PHASE3 INTERVENTIONAL 2-arm NCT00167232

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence

Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Alcoholism Cocaine Dependence

Interventions Naltrexone

Updated 6 times since 2017 Last updated: Feb 26, 2018 Started: Jan 31, 1998 Primary completion: Feb 28, 2003 Completion: Jul 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Alcoholism and Cocaine Dependence and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States